<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Decreases in both mass and secretory function of insulin-producing beta-cells contribute to the pathophysiology of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>The histology of islets from patients with type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> displays an inflammatory process characterized by the presence of cytokines, apoptotic cells, immune cell infiltration, amyloid deposits, and eventually <z:mp ids='MP_0003045'>fibrosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>This inflammatory process is probably the combined consequence of <z:e sem="disease" ids="C0242339" disease_type="Disease or Syndrome" abbrv="">dyslipidemia</z:e>, <z:hpo ids='HP_0003074'>hyperglycemia</z:hpo>, and increased circulating adipokines </plain></SENT>
<SENT sid="3" pm="."><plain>Therefore, modulation of intra-islet <z:mp ids='MP_0002501'>inflammatory mediators</z:mp>, in particular interleukin-1 beta, appears as a promising therapeutic approach </plain></SENT>
</text></document>